Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
58.80
-0.80 (-1.34%)
At close: Apr 27, 2026
15.75% (1Y)
| Market Cap | 6.32B |
| Revenue (ttm) | 10.07B |
| Net Income (ttm) | 609.04M |
| Shares Out | 107.42M |
| EPS (ttm) | 5.65 |
| PE Ratio | 10.41 |
| Forward PE | n/a |
| Dividend | 1.40 (2.38%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 458,499 |
| Average Volume | 425,565 |
| Open | 60.00 |
| Previous Close | 59.60 |
| Day's Range | 58.50 - 60.00 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | 0.08 |
| RSI | 50.71 |
| Earnings Date | Jan 28, 2026 |